Itolizumab

Thursday, April 25, 2024

NEWS

Itolizumab

Cuba increases production of Itolizumab against Covid-19

Published on: September 1, 2021
16:16

Havana, Sep 1 (Prensa Latina) A production campaign of Itolizumab, a monoclonal antibody used as a treatment for serious Covid-19 cases was recently completed, informed today authorities of the Center for Molecular Immunology (CIM) of Cuba.

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

Radio – Publications – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado, Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division Prensa Latina.

Itolizumab

Cuba increases production of Itolizumab against Covid-19

LATEST NEWS